Amnestic Mild Cognitive Impairment: Structural MR Imaging Findings Predictive of Conversion to Alzheimer Disease

References

1. ↵
   Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183–94

   CrossRefPubMedWeb of Science
2. ↵
   Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985–92

   CrossRefPubMedWeb of Science
3. ↵
   Grundman M, Jack CR Jr, Petersen RC, et al. Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment. J Mol Neurosci 2003;20:241–48

   CrossRefPubMedWeb of Science
4. ↵
   Jack CR Jr, Shiung MM, Weigand SD, et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 2005;65:1227–31

   Abstract/FREE Full Text
5. ↵
   Baron JC, Chetelat G, Desgranges B, et al. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 2001;14:298–309

   CrossRefPubMedWeb of Science
6. ↵
   Chetelat G, Desgranges B, De La Sayette V, et al. Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology 2003;60:1374–77

   Abstract/FREE Full Text
7. Pennanen C, Testa C, Laakso MP, et al. A voxel-based morphometry study on mild cognitive impairment. J Neurol Neurosurg Psychiatry 2005;76:11–14

   Abstract/FREE Full Text
8. ↵
   Karas GB, Scheltens P, Rombouts SA, et al. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage 2004;23:708–16

   CrossRefPubMedWeb of Science
9. ↵
   van der Flier WM, van den Heuvel DM, Weverling-Rijnsburger AW, et al. Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann Neurol 2002;52:62–67

   CrossRefPubMedWeb of Science
10. ↵
    Devanand DP, Pradhaban G, Liu X, et al. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 2007;68:828–36

    Abstract/FREE Full Text
11. ↵
    Apostolova LG, Dutton RA, Dinov ID, et al. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol 2006;63:693–99

    CrossRefPubMedWeb of Science
12. ↵
    Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98

    CrossRefPubMedWeb of Science
13. ↵
    McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939–44

    Abstract/FREE Full Text
14. ↵
    Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 1997;9 (suppl 1):173–76, discussion 177–78

    CrossRefPubMed
15. ↵
    Scheltens P, Leys D, Barkhof F, et al. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992;55:967–72

    Abstract/FREE Full Text
16. ↵
    Korf ES, Wahlund LO, Visser PJ, et al. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 2004;63:94–100

    Abstract/FREE Full Text
17. ↵
    Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479–89

    CrossRefPubMedWeb of Science
18. ↵
    Ashburner J, Friston KJ. Voxel-based morphometry: the methods. Neuroimage 2000;11:805–21

    CrossRefPubMedWeb of Science
19. ↵
    Karas GB, Burton EJ, Rombouts SA, et al. A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage 2003;18:895–907

    CrossRefPubMedWeb of Science
20. ↵
    Smith SM. Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143–55

    CrossRefPubMedWeb of Science
21. ↵
    Woods RP. Characterizing volume and surface deformations in an atlas framework: theory, applications, and implementation. Neuroimage 2003;18:769–88

    CrossRefPubMedWeb of Science
22. ↵
    Davatzikos C, Genc A, Xu D, et al. Voxel-based morphometry using the RAVENS maps: methods and validation using simulated longitudinal atrophy. Neuroimage 2001;14:1361–69

    CrossRefPubMedWeb of Science
23. ↵
    Brett M, Anton JL, Valabregue R, et al. Region of interest analysis using an SPM toolbox. Presented at: 8th International Conference on Functional Mapping of the Human Brain, Sendai, Japan, June 2–6,2002
24. ↵
    Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273–89

    CrossRefPubMedWeb of Science
25. ↵
    Chetelat G, Landeau B, Eustache F, et al. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage 2005;27:934–46

    CrossRefPubMedWeb of Science
26. ↵
    Bell-McGinty S, Lopez OL, Meltzer CC, et al. Differential cortical atrophy in subgroups of mild cognitive impairment. Arch Neurol 2005;62:1393–97

    CrossRefPubMedWeb of Science
27. DeToledo-Morrell L, Stoub TR, Bulgakova M, et al. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging 2004;25:1197–203

    CrossRefPubMedWeb of Science
28. ↵
    Killiany RJ, Hyman BT, Gomez-Isla T, et al. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology 2002;58:1188–96

    Abstract/FREE Full Text
29. ↵
    Braak E, Griffing K, Arai K, et al. Neuropathology of Alzheimer's disease: what is new since A. Alzheimer? Eur Arch Psychiatry Clin Neurosci 1999;249 (suppl 3):14–22
30. ↵
    Chetelat G, Desgranges B, De La Sayette V, et al. Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment. Brain 2003;126:1955–67

    Abstract/FREE Full Text
31. ↵
    Borroni B, Anchisi D, Paghera B, et al. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiol Aging 2006;27:24–31. Epub 2005 Mar 24

    CrossRefPubMedWeb of Science
32. Drzezga A, Grimmer T, Riemenschneider M, et al. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET. J Nucl Med 2005;46:1625–32

    Abstract/FREE Full Text
33. Drzezga A, Lautenschlager N, Siebner H, et al. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging 2003;30:1104–13

    CrossRefPubMedWeb of Science
34. ↵
    Anchisi D, Borroni B, Franceschi M, et al. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol 2005;62:1728–33

    CrossRefPubMedWeb of Science
35. ↵
    Ashburner J, Friston KJ. Why voxel-based morphometry should be used. Neuroimage 2001;14:1238–43

    CrossRefPubMedWeb of Science
36. ↵
    Bookstein FL. “Voxel-based morphometry” should not be used with imperfectly registered images. Neuroimage 2001;14:1454–62

    CrossRefPubMedWeb of Science
37. ↵
    Thompson PM, Mega MS, Woods RP, et al. Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Cereb Cortex 2001;11:1–16

    Abstract/FREE Full Text